Risk of radiation-induced second malignant neoplasms from photon and proton radiotherapy in paediatric abdominal neuroblastoma
08/07/2021
/
Publications
/
Secondary cancer
This study compared the carcinogenic risk associated with 3D-CRT, IMAT and PBS-PT)in the treatment of pediatric abdominal neuroblastoma. The risk of radiation...
Current Situation of Proton Therapy for Hodgkin Lymphoma: From Expectations to Evidence
08/07/2021
/
Publications
/
Secondary cancer
Consolidative radiation therapy (RT) is of prime importance for early-stage Hodgkin lymphoma (HL) management since it significantly increases progression-free...
Proton Radiotherapy to Reduce Late Complications in Childhood Head and Neck Cancers
08/06/2021
/
Publications
/
Toxicity
Secondary cancer
Proton beam therapy is accepted as a preferred radiation modality in pediatric cancers to minimize the late radiation side effects. This review compared the...
Pediatric proton therapy
08/09/2019
/
Publications
/
Dosimetry
Secondary cancer
A review article that emphasizes proton beam therapy is an important therapeutic component in multidisciplinary management in pediatric oncology because of...
Outcomes following proton therapy for Ewing sarcoma of the cranium and skull base.
17/11/2019
/
Publications
/
Secondary cancer
This study by the University of Florida, Jacksonville, reviewed 25 patients (≤21 years old) with nonmetastatic Ewing sarcoma of the cranium and skull base...
Hadrontherapy for cancer. An overview of HTA reports and ongoing studies
12/12/2019
/
Publications
/
Secondary cancer
Hadron therapy often refers to proton therapy (PBT) and carbon ion therapy (CIRT) are not new technologies, but have been subject to assessment by several...
Comparing second cancer risk for multiple radiotherapy modalities in survivors of Hodgkin lymphoma
10/04/2021
/
Publications
/
Secondary cancer
VMAT
Using Excess Absolute Risk (EAR) models, this study compared the risk of secondary cancer for Hodgkin lymphoma survivors after either IMRT or PBT radiation...
Secondary Malignancy Risk Following Proton vs. X-ray Treatment of Mediastinal Malignant Lymphoma: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk.
10/10/2020
/
Publications
/
IMRT
Secondary cancer
This study estimated secondary cancer risks for 23 mediastinal lymphoma patients treated with PBT in comparison with helical photon IMRT re-plans. PBT was...
Proton pencil beam scanning reduces secondary cancer risk in breast cancer patients with internal mammary chain involvement compared to photon radiotherapy.
01/10/2020
/
Publications
/
Secondary cancer
This study compared tangential 3D-CRT and VMAT to PBS proton therapy in secondary cancer risk (SCR) for the lungs and for contralateral breast. PBS PT was...
Second tumor risk in children treated with proton therapy.
04/02/2021
/
Publications
/
Secondary cancer
Published in Pediatric Blood & Cancer, this study by the Jacksonville group evaluated the secondary tumor risk based on the data of 1713 children that underwent...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.